November 17, 2011 - Medical Simulation Corp. (MSC) launched an easy-to-use, portable, high-fidelity endovascular procedural simulator at TCT 2011. The Compass simulator is small enough to fit in one shipping case and can be checked as luggage on an airplane. It takes less than five minutes to set up and can be easily used in the physician's office.

Medtronic and Bain Capital, a global private investment firm, today announced they have entered into a definitive agreement under which affiliates of Bain Capital will acquire Physio-Control. The stock of Physio-Control and related entities will be purchased for cash in a transaction valued at approximately $487 million.


Each year I attend Transcatheter Cardiovascular Therapeutics (TCT), I comb the event and its sessions looking for the next big trend or technological innovations in cardiovascular devices. Below are my finds for the most cutting-edge and futuristic technologies at TCT 2011.

November 16, 2011 — MedSolutions announced the launch of its Implantable Cardioverter Defibrillator (ICD) Surgery Management Program. The system uses evidence-based guidelines to ensure the clinical appropriateness of ICD and cardiac resynchronization therapy defibrillator (CRT-D) implantation and directs members to the most qualified physicians and facilities.

November 16, 2011 — The American Society of Echocardiography (ASE) issued a response voicing concerns over the implications of a study published this week in the Journal of the American Medical Association (JAMA).

November 16, 2011 – BSP Biological Signal Processing, which develops and manufactures products for the non-invasive, accurate diagnosis of coronary artery disease (CAD), recently announced the successful completion of a comprehensive clinical research study evaluating the performance of the company’s HyperQ technology in diagnosing CAD. An article describing the study and its results was accepted for publication in the American Journal of Cardiology.

 

November 16, 2011 — Heart failure patients with a previous myocardial infarction showed an average of 12 percent improvement one year following an investigative treatment that infused them with their own stem cells. The results triple the 4 percent improvement average the researchers projected for the Phase I trial.

November 16, 2011 – Cambridge Consultants unveiled how it has collaborated with start-up company EBR Systems to develop the world’s first wireless pacing system.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now